Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
ARIES® GBS Assay Outperforms Culture Testing in a Multisite Study
Results show excellent clinical performance, sensitivity, specificity, reproducibility, and ease of use
A new publication released in the Journal of Clinical Microbiology reports results of a multisite analysis of the ARIES® GBS Assay. Lead author Diana R. Hernandez from Geisinger, senior author Arundhati Rao from Baylor Scott and White Health, and collaborators issued their findings in the paper entitled “Multicenter Diagnostic Accuracy Evaluation of the Luminex® ARIES® Real-Time PCR Assay for Group B Streptococcus detection in Lim-Enriched samples.”
Continue Reading >
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.